GlassScriptPhysician profile
Cianna Pender
NPI 1376832261
$3,115.37
in general payments reported to CMS, 2019-2025
21 companies · $335 in 2025
The $335 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $170 · 2020: $11.24 · 2021: $1,298 · 2022: $34.31 · 2023: $915 · 2024: $351 · 2025: $335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,567 · Travel and Lodging: $19.00 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,566.52 |
| Travel and Lodging | $19.00 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,909.44 | 2021-2025 | Da Vinci Surgical System |
| Myriad Genetic Laboratories, INC. | $324.68 | 2023 | Bracanalysis Cdx, Myrisk |
| Hologic Sales and Service, LLC | $121.07 | 2023-2024 | Localizer, Trunode, Biozorb |
| Organogenesis INC. | $104.68 | 2024-2025 | Affinity, Apligraf |
| Pacira Pharmaceuticals Incorporated | $91.41 | 2023-2025 | Exparel |
| Merck Sharp & Dohme LLC | $86.16 | 2022-2025 | Keytruda, Lynparza |
| Ethicon US, LLC | $71.58 | 2025 | Echelon Endopath, Vistaseal, Stratafix |
| Veran Medical Technologies, INC. | $69.89 | 2019 | |
| Davol INC. | $60.04 | 2019 | |
| Kls-Martin L.P. | $53.90 | 2021-2023 | |
| Abbvie INC. | $33.03 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $30.45 | 2025 | Libtayo |
| Genentech USA, INC. | $24.39 | 2023 | Tecentriq |
| Allergan, INC. | $23.88 | 2019 | |
| Elucent Medical | $23.33 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $21.23 | 2024 | Collagenase Santyl |
| Portola Pharmaceuticals, LLC | $16.33 | 2019 | |
| Medtronic, INC. | $14.34 | 2023 | Ligasure |
| Olympus America INC. | $12.65 | 2021 | |
| Bioventus LLC | $11.65 | 2022 | |
| Focal Therapeutics, INC. | $11.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cianna Pender listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.